NASDAQ:GOVX GeoVax Labs Q4 2025 Earnings Report $0.32 0.00 (-0.65%) Closing price 04:00 PM EasternExtended Trading$0.31 -0.01 (-1.91%) As of 05:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast GeoVax Labs EPS ResultsActual EPS$1.85Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AGeoVax Labs Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AGeoVax Labs Announcement DetailsQuarterQ4 2025Date4/15/2026TimeAfter Market ClosesConference Call DateWednesday, April 15, 2026Conference Call Time7:00AM ETUpcoming EarningsGeoVax Labs' Q3 2026 earnings is estimated for Thursday, November 12, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Annual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K) GeoVax Labs Earnings HeadlinesGeoVax Highlights Likely Sustained Clade Ib Mpox Transmission in the United StatesSeptember 29 at 9:23 AM | finance.yahoo.comGeoVax Next-Generation MVA Vaccine Demonstrates Durable Single-Dose Protection in Preclinical ModelsSeptember 21, 2026 | finance.yahoo.comThey're not buying gold. They're buying this.Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, and Millennium by 122%. Kopernik Global made it their largest holding, owning roughly 8% of the company. It holds rights to an 88 million ounce deposit with existing roads, power, and permits that never expire. Market cap sits near $4 billion against a deposit worth hundreds of billions at current gold prices.October 2 at 1:00 AM | Behind the Markets (Ad)GeoVax Confirms Bundibugyo Ebola Vaccine ConstructSeptember 16, 2026 | finance.yahoo.comGeoVax and CEPI Enter Agreement to Utilize CEPI Centralised Laboratory Network to Support GEO-MVA Phase 3 TrialSeptember 14, 2026 | finance.yahoo.comGeoVax Provides Nasdaq Listing Update and Reaffirms Focus on Advancing Strategic PrioritiesSeptember 10, 2026 | finance.yahoo.comSee More GeoVax Labs Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like GeoVax Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GeoVax Labs and other key companies, straight to your email. Email Address About GeoVax LabsGeoVax Labs (NASDAQ:GOVX), Inc. is a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer. The company’s research programs are based primarily on modified vaccinia Ankara (MVA) and virus-like particle technologies, which are designed to stimulate broad and durable immune responses. GeoVax’s pipeline has included GEO-CM04S1, an investigational COVID-19 vaccine candidate intended to generate immune responses against multiple viral components, as well as vaccine programs targeting HIV. The company is also researching immunotherapies and vaccine-based approaches for selected cancers and other infectious diseases. Based in Atlanta, Georgia, GeoVax has conducted development activities and clinical research through collaborations with government agencies, academic institutions and other research organizations. Its products remain investigational and are subject to clinical testing and regulatory review before they can be marketed.View GeoVax Labs ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Time to Nibble on MCD Stock After it Enters Oversold Territory?McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes NextTarget's Holiday Blitz: Slashing Prices to Capture Market Share Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
